D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Quest Diagnostics
DGX
$25.1B
| $36.2M | 0.03% |
281,819
+184,722
| +190% | +$22.8M |
|
577
Corpay
CPAY
$24.2B
| $36.1M | 0.03% |
134,308
+17,661
| +15% | +$4.8M |
|
578
Incyte
INCY
$23.5B
| $35.8M | 0.03% |
440,568
+99,456
| +29% | +$8.49M |
|
579
Heron Therapeutics
HRTX
$86.3M
| $35.8M | 0.03% |
2,207,390
-53,888
| -2% | -$961K |
|
580
PUT
Meta Platforms (Facebook)
META
$1.51T
| $35.8M | 0.03% |
121,400
-113,900
| -48% | -$30.7M |
|
581
Tapestry
TPR
$28.8B
| $35.7M | 0.03% |
867,424
-1,336,444
| -61% | -$51.5M |
|
582
C.H. Robinson
CHRW
$22B
| $35.7M | 0.03% |
374,169
-2,719
| -0.7% | -$254K |
|
|
CHNGU
583
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| $35.7M | 0.03% |
480,259
+180,259
| +60% | +$14.1M |
|
584
CALL
Lyft
LYFT
$5.39B
| $35.5M | 0.03% |
561,500
+253,200
| +82% | +$14.1M |
|
585
CALL
Lockheed Martin
LMT
$134B
| $35.3M | 0.03% |
95,600
-19,500
| -17% | -$6.69M |
|
586
Green Plains
GPRE
$1.19B
| $35.3M | 0.03% |
1,302,818
+8,496
| +0.7% | +$195K |
|
587
CALL
BP
BP
$113B
| $35.1M | 0.03% |
1,440,200
+665,700
| +86% | +$16M |
|
588
CDW
CDW
$17.1B
| $34.9M | 0.03% |
210,816
-42,710
| -17% | -$6.38M |
|
589
CALL
AbbVie
ABBV
$458B
| $34.9M | 0.03% |
322,600
-291,400
| -47% | -$31.2M |
|
590
Brookfield Renewable
BEPC
$6.12B
| $34.8M | 0.03% |
744,016
+297,708
| +67% | +$15.2M |
|
591
TripAdvisor
TRIP
$1.59B
| $34.8M | 0.03% |
646,828
+359,502
| +125% | +$15.4M |
|
592
PUT
DexCom
DXCM
$27.6B
| $34.8M | 0.03% |
387,200
-44,800
| -10% | -$4.21M |
|
593
Eaton
ETN
$157B
| $34.7M | 0.03% |
251,073
+131,544
| +110% | +$17M |
|
594
PUT
Chevron
CVX
$388B
| $34.7M | 0.03% |
330,900
-207,000
| -38% | -$20.2M |
|
595
ResMed
RMD
$28.3B
| $34.4M | 0.03% |
177,184
+173,932
| +5,348% | +$34.9M |
|
596
Trimble
TRMB
$12.3B
| $34.3M | 0.03% |
441,102
-823,658
| -65% | -$59.5M |
|
597
Zions Bancorporation
ZION
$10.1B
| $34.3M | 0.03% |
623,290
+254,188
| +69% | +$13.1M |
|
|
598
CALL
Chevron
CVX
$388B
| $34.2M | 0.03% |
326,000
-172,000
| -35% | -$16.8M |
|
599
Equitable Holdings
EQH
$13.1B
| $34.2M | 0.03% |
1,047,093
-151,608
| -13% | -$4.37M |
|
|
GFLU
600
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
| $34.1M | 0.03% |
418,246
+288,500
| +222% | +$21.2M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.